ASROF yields 210.11% · PFE yields 6.13%● Live data
📍 ASROF pulled ahead of the other in Year 1
Combined, ASROF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASROF + PFE for your $10,000?
Astrocast SA, an Internet of Things (IoT) focused nanosatellite company, provides satellite IoT connectivity services to track, monitor, manage, and communicate with assets in remote regions worldwide. Its products portfolio includes the Astronode S, a bidirectional satellite communication module for connecting IoT devices to the Astrocast nanosatellite network; Astronode S+, a ready-to-install satellite communication device; Astronode DevKit, which has the Astronode S architecture that enables to connect your assets to the Astrocast nanosatellite network; and Patch Antenna, a miniaturized antenna designed for communication with Astrocast's constellation of IoT satellites in LEO. The company also offers Astrocast Portal that allows customers to manage their Astronode S modules and devices through a web application; and Astrocast API, which allows customers to manage their Astronode S modules and devices, retrieve messages received from their assets, and send commands back through a secure REST API built on standard JSON messages. It serves various industries, such as agriculture and livestock; environment and utilities; maritime; land transport; mining; and oil and gas. Astrocast SA was incorporated in 2014 and is based in Chavannes-Renens, Switzerland.
Full ASROF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.